Overview of parainfluenza

Medical personnel refer to the class of infectious organisms known as human parainfluenza viruses (HPIVs) as "parainfluenza." Parainfluenza viruses cause numerous disorders of the lower and upper respiratory tract. Shortness of breath, coughing, and sore throat are some of the mild to major symptoms of respiratory infections. Infections with HPIV can strike anyone. They are typical in young children and newborns. Even if you have experienced an HPIV infection before, you could still have it again in your lifetime. Your chances of developing a serious illness are reduced after your first infection, which typically occurs in childhood. There is a seasonal pattern to HPIV infections, with autumn, winter, and spring being the periods where they are most common.¹

The enveloped, negative-sense, single-stranded RNA virus known as the human parainfluenza virus (HPIV) is a member of the Paramyxoviridae family. It is divided into four serotypes (HPIV-1, HPIV-2, HPIV-3, and HPIV-4) with numbers ranging from one to four. Even further divisions into HPIV-4A and HPIV-4B exist for serotype four. Both upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs) can be brought on by HPIV in adults, immunocompromised adults, elderly people, and children, typically under the age of five. It is one of the main global causes of newborn morbidity and death.² Although each child's symptoms may differ, the following are the most typical: a running nose, redness, or eye swelling, loud, hard breathing, barky cough, voice or yell that sounds hoarse, rattling sensation over the chest or back, wheezing, fever, and irritation, diminished hunger diarrhoea and vomiting.³

Transmission pathways of HPIVs⁴

Human parainfluenza viruses (HPIVs) typically infect people through the following methods:

• The air through sneezing and coughing with close contact, including handshaking or touching
• Engaging in surfaces or items that contain HPIVs, then touching your lips, nose, or eyes 

Understanding incubation period

An HPIV infection typically takes two to six days to incubate. Children with a primary HPIV infection can shed the virus from up to a week before symptoms appear and continue shedding for more than three weeks after symptoms subside, depending on the serotype. Children with primary HPIV-1 infection shed viral RNA for up to two weeks, as shown by polymerase chain reaction (PCR), and cultivable virus for four to seven days.⁵ HPIVs are spread through intimate touch, respiratory droplets, and minor aerosol transfer over short distances. According to volunteer research, HPIV also maintains its capacity for infection on nonliving things for up to 10 hours, and its incubation period is believed to be between 3 and 6 days.⁶

Indications and disorders

Usually ranging from two to six days, the incubation period is the interval between HPIV infection and the development of symptoms.

• The most common viruses linked to croup are HPIV-1 and HPIV-2, with HPIV-1 being the most frequently found cause in youngsters. In addition, both can cause upper and lower respiratory tract infections and symptoms akin to a cold
• More frequently, bronchiolitis, bronchitis, and pneumonia are linked to HPIV-3
• Despite being less well-known, HPIV-4 can cause mild to severe respiratory tract infections

Any HPIV upper respiratory illness often presents with symptoms that are comparable to a cold. Among the symptoms and indicators are:

• A fever
• A running nose and cough
• A sore throat

Additional signs of HPIV disease could be:

• An ear ache
• Diminished hunger

HPIVs can also cause serious illnesses. Children's clinical syndromes include:

• Croup, which is an infection of the windpipe (trachea), voice cords (larynx), and occasionally the bronchial tubes (bronchi)
• Bronchitis (infection of the major airways that join the lungs and windpipe)
• Bronchiolitis (infection of the lungs' tiniest airways)
• Pneumonia (pulmonary infection)

Indications of a more severe sickness could be:

• Barking cough and husky voice
• Stridor (high-pitched or loud breathing noise)
• Wheezing

The most frequent illnesses in adults caused by HPIVs are upper respiratory infections and bronchitis. Symptoms might include fever, a running nose, coughing, and sore throat. In particular, older people and those with compromised immune systems are more susceptible to pneumonia.⁴

Diagnosis

There are numerous methods for making a diagnosis, including a variety of complicated steps:⁷

• Isolation and identification of the virus in cultured cells
• Direct detection of viral antigens in body fluids with the use of fluoro immunoassays, enzyme immunoassays, or immunofluorescence
• PCR stands for polymerase chain reaction
• Examination of particular IgG antibodies demonstrating an increase in titre after infection (using matched serum specimens)

The utilization of hemagglutination assay (HA) or hemadsorption inhibition (HAdI) procedures is common due to the viruses' comparable antigenic profiles. Viral serotype differentiation can also be aided by the use of enzyme-linked immunosorbent assays (ELISA) and complement fixation and neutralization.⁸ To diagnose illnesses caused by HPIVs, doctors typically perform physical exams and ask you about your symptoms. During the examination, they may:

• Pay attention to your lungs and heart
• Examine your mouth and nose
• In order to take your blood pressure, place a cuff around your arm
• To find out how much oxygen is in your blood, use a pulse oximeter, sometimes called a pulse ox, that is attached to your finger⁹

Evaluation

While HPIV-1, or human parainfluenza virus, is frequently linked to croup and can only be diagnosed clinically based on clinical presentations, other HPIV serotypes lack specific clinical traits that require a clinical diagnosis [10]. Therefore, to diagnose a particular virus, laboratory testing is required.^10,11 It is recommended to use flocked swabs instead of cotton swabs for swab collection because they yield more. Nasopharyngeal swabs, nasal aspiration and washes, nose and throat swabs, sputum, and bronchoalveolar lavage are only a few of the many sample types that are permitted for testing. The timing at which the sample is obtained is essential. As upper airway samples have shown promising results early in the disease, it is easier to analyze them at this stage. Later in the disease, it is preferable to examine secretions like sputum and bronchoalveolar fluid from the lower airways.¹⁰

HPIV-3 has been isolated in youngsters from as early as 6 days prior to 6 weeks past their initial symptom. It has been shown that immunocompromised individuals and adults shed HPIV-1, HPIV-2, and HPIV-3 for several months.¹¹

Viral culture: Viral culture has been considered the most dependable diagnostic technique for a long time. The occurrence of either of the two processes hemadsorption detection to monolayers or the formation of structural alterations in host cells known as the cytopathic effect or CPE is crucial for the separation of viruses in cell cultures¹⁰ Viral-specific fluorescent-labelled monoclonal antibodies (Mab) can be used to validate the hemadsorption and CPE.¹⁰ Because it requires a lot of work and takes longer to get results, viral culture is rarely employed.¹²

Fluorescent antibody assays: This quick diagnosis technique has been around since the 1970s and works by directly identifying viral antigens on patient samples. Commercial colourimetric enzyme-linked immunoassays (EIAs) have been developed for many viruses; however, a commercial fast antigen test for the parainfluenza virus is currently unavailable. With sensitivity ranges of 63 to 95%, specific immunofluorescent-labeled antibodies can be used for the direct detection of HPIV 1-3; however, there are currently no antibodies available for HPIV-4. Therefore, clinical samples examined by the immunofluorescent assay (IFA) may be a reasonable substitute due to the reduction in the clinical characteristics of the HPIV infection.¹⁰

Molecular evaluation: Polymerase Chain Reaction (PCR) assays are a simple and effective way to identify and diagnose HPIV infection. In terms of sensitivity, specificity, and speed, PCR is the most reliable test for diagnosing HPIV. It has been found that PCR exhibits superior sensitivity and specificity compared to IFA testing and viral culture. The established commercial tests became more widely available for use in clinical microbiology laboratories as they grew more accessible.¹⁰

Serologic diagnosis: is mostly employed as a research tool and is rarely used in clinical practice.¹⁰

Case study

The latest research found that the prevalence of HPIVs (human parainfluenza viruses) was 7.7%, making it the second most frequent virus after HRSV (respiratory syncytial virus), which had a 26.5% occurrence. The results of other research with a similar design are supported by this outcome. Because IIF has a 50–75% sensitivity and good specificity, we have chosen it as our method of viral study. According to some publications, PCR and Real-Time PCR are more sensitive than IIF and culture procedures by 10–20% when it comes to detecting HPIVs, although they additionally come at a higher cost. In the first two years of the study, the highest rates of HPIV isolation (discovery) happened in the autumn, which also happened to be the season when the HRSV was most prevalent. In the United States, the traditional seasonal pattern of HPIV infection is reported, with biannual peaks of HPIV1 occurring in the autumn and winter and annual peaks of HPIV3, especially in the late winter or early spring. There is little research conducted in tropical nations, however, one study in Rio de Janeiro found seasonal peaks of HPIV3 at the end of winter and in the spring, while two other studies conducted in Northeastern and Southern Brazil found maxima in October, which matched with spring.¹³

Summary

Human parainfluenza viruses (HPIVs) are responsible for respiratory infections affecting both the upper and lower respiratory tracts, especially in young children and immunocompromised individuals. The virus is classified into four serotypes (HPIV-1 to HPIV-4), with HPIV-1 and HPIV-2 most commonly causing croup, and HPIV-3 linked to more severe lower respiratory conditions like bronchiolitis and pneumonia.

The incubation period for HPIV is typically 2 to 6 days, and the virus is highly contagious, and transmitted through respiratory droplets, direct contact, or contaminated surfaces. Symptoms of HIV infection include fever, runny nose, cough, sore throat, and, in severe cases, wheezing, barking cough, and stridor.

HPIV infections are most common in autumn, winter, and spring. While diagnosis is often clinical, laboratory tests such as PCR, viral culture, and immunofluorescent assays are used for confirmation. In children, HPIV infections can lead to serious illnesses like croup and pneumonia, while adults usually experience milder symptoms. The virus remains a major cause of morbidity in young children globally.